Philippe Ledru Net Worth

What's Philippe Ledru's mailing address?

Philippe's mailing address filed with the SEC is C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO, A6, M2J 4R3.

Insiders trading at Aptose Biosciences Inc

Over the last 6 years, insiders at Aptose Biosciences Inc have traded over $2,827,381 worth of Aptose Biosciences Inc stock and bought 538,629 units worth $767,189 . The most active insiders traders include Erich Platzer, Bernd R. Seizinger et William G. Rice. On average, Aptose Biosciences Inc executives and independent directors trade stock every 59 days with the average trade being worth of $14,277. The most recent stock trade was executed by Bernd R. Seizinger on 22 September 2023, trading 17,000 units of APTO stock currently worth $53,380.

What does Aptose Biosciences Inc do?

aptose biosciences is a science-driven biotechnology company advancing first-in-class agents to treat life-threatening cancers, such as acute myeloid leukemia (aml), high-risk myelodysplastic syndromes (mds) and other hematologic malignancies. based on insights into the genetic and epigenetic profiles of certain cancers and patient populations, aptose is building a pipeline of novel oncology therapies directed at dysregulated processes and signaling pathways. aptose is developing targeted medicines for precision treatment of these diseases, based on a patient’s specific gene expression signature. in the treatment of cancer, this strategy is intended to optimize efficacy and quality of life by minimizing the cytotoxic side effects associated with conventional therapies. cg026806 (cg’806) is a highly potent first-in-class pan-flt3/btk inhibitor. this small molecule therapeutic agent, exhibits a picomolar ic50 toward the fms-like tyrosine kinase 3 with the internal tandem duplication (flt

Aptose Biosciences Inc executives and stock owners

Aptose Biosciences Inc executives and other stock owners filed with the SEC include:

• William Rice,
  Chairman of the Board, President, Chief Executive Officer
• Gregory Chow,
  Chief Financial Officer, Executive Vice President
• Jotin Marango,
  Senior Vice President, Chief Business Officer
• Dr. William G. Rice Ph.D.,
  Chairman, Pres & CEO
• Dr. Jotin Marango Ph.D., M.D.,
  Sr. VP, CFO, Chief Accounting Officer & Chief Bus. Officer
• Dr. Rafael Bejar M.D., Ph.D.,
  Sr. VP & Chief Medical Officer
• Denis Burger,
  Lead Independent Director
• Caroline Loewy,
  Independent Director
• Carol Ashe,
  Independent Director
• Warren Whitehead,
  Independent Director
• Mark Vincent,
  Independent Director
• Erich Platzer,
  Independent Director
• Rafael Bejar,
  Senior Vice President, Chief Medical Officer
• Roger Davies B.Sc.,
  VP of Operations
• Bernd R. Seizinger,
  
• Fletcher Payne,
  Sr VP and CFO
• Philippe Ledru,